Bisphosphonate-prodrugs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8778914
APP PUB NO 20120165296A1
SERIAL NO

13391367

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a prodrug, comprising a pharmaceutically and/or diagnostically active compound, and one or more bisphosphonate groups, to a process for producing such a prodrug, and to a pharmaceutical composition comprising said prodrug, to be used for the treatment of bone-related disorders such as bone cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VERGELL MEDICAL S ARUE DE L'EVECHE 5 GENEVA 1204

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hochdoerffer, Katrin Freiburg, DE 2 4
Kratz, Felix Ehrenkirchen, DE 31 269

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 15, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00